References
- Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, et al. Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage. JAMA. 2007;298:1429–1438.
- Kopczak A, Kilimann I, Rosen von F, et al. Screening for hypopituitarism in 509 patients with traumatic brain injury or subarachnoid hemorrhage. J Neurotrauma. 2014;31:99–107.
- Dimopoulou I, Kouyialis AT, Tzanella M, et al. High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:2884–2889.
- Kreitschmann-Andermahr, I. Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage. J Clin Endocrinol Metab. 2004;89:4986–4992.
- The Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage, Vespa P. Endocrine function following acute SAH. Neurocritical Care. 2011;15:361–364.
- Vespa PM. Hormonal dysfunction in neurocritical patients. Curr Opin Crit Care. 2013;19:107–112.
- Bendel S, Koivisto T, Ruokonen E, et al. Pituitary-adrenal function in patients with acute subarachnoid haemorrhage: a prospective cohort study. Critical Care. 2008;12:R126.
- Mangieri P, Suzuki K, Ferreira M, et al. Evaluation of pituitary and thyroid hormones in patients with subarachnoid hemorrhage due to ruptured intracranial aneurysm. Arq Neuropsiquiatr. 2003;61:14–19.
- Poll E-M, Boström A, Bürgel U, et al. Cortisol dynamics in the acute phase of aneurysmal subarachnoid hemorrhage: associations with disease severity and outcome. J Neurotrauma. 2010;27:189–195.
- Parenti G, Cecchi PC, Ragghianti B, et al. Evaluation of the anterior pituitary function in the acute phase after spontaneous subarachnoid hemorrhage. J Endocrinological Invest. 2011;34:361.
- Zetterling M, Engström BE, Hallberg L, et al. Cortisol and adrenocorticotropic hormone dynamics in the acute phase of subarachnoid haemorrhage. Br J Neurosurg. 2011;25:684–692.
- Tanriverdi F, Dagli AT, Karaca Z, et al. High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: A prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin Endocrinol. 2007;67:931–937.
- Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1–9.
- Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.
- Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937–1949.
- Jennett B, Teasdale G, Braakman R, et al. Predicting outcome in individual patients after severe head injury. Lancet. 1976;1:1031–1034.
- Klose M, Brennum J, Poulsgaard L, et al. Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage. Clin Endocrinol. 2010;73:95–101.
- Zetterling M, Engström BE, Arnardottir S, et al. Somatotropic and thyroid hormones in the acute phase of subarachnoid haemorrhage. Acta Neurochir (Wien) 2013;155:2053–2062.
- Pereira JL, Albuquerque LA, Dellaretti M, et al. Pituitary deficiency after aneurysmal subarachnoid hemorrhage. Clinics. 2013;68:745–749.
- Schilling T, Gründling M, Strang CM, Möritz K-U, Siegmund W, Hachenberg T. Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients. Intensive Care Med. 2004;30:1127–1133.
- Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med. 1996;24:1580–1590.
- Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med. 2011;37:901–910.
- Boonen E, Vervenne H, Meersseman P, et al. Reduced cortisol metabolism during critical illness. N Engl J Med. 2013;368:1477–1488.
- Peeters B, Boonen E, Langouche L, et al. The HPA axis response to critical illness: New study results with diagnostic and therapeutic implications. Mol Cell Endocrinol. 2015;408:235–240.
- Boonen E, Langouche L, Janssens T, et al. Impact of duration of critical illness on the adrenal glands of human intensive care patients. J Clin Endocrinol Metab. 2014;99:4214–4222.
- Kreitschmann-Andermahr I, Poll EM, Reineke A, et al. Diagnosing neuroendocrine dysfunction in patients after aneurysmal subarachnoid hemorrhage in clinical practice - does basal hormone screening make sense? Exp Clin Endocrinol Diabetes. 2008;116:276–281.
- Langouche L, Van den Berghe G. Hypothalamic-pituitary hormones during critical illness: a dynamic neuroendocrine response. 1st ed. Elsevier B.V.; 2014:115–126.
- Chen DK, So YT, Fisher RS. Use of serum prolactin in diagnosing epileptic seizures: Report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology. 2005;65:668–675.
- Vukmir RB. Does serum prolactin indicate the presence of seizure in the emergency department patient? J Neurol. 2004;251:736–739.
- Molitch ME. Drugs and prolactin. Pituitary. 2008;11:209–218.
- Ascoli P, Cavagnini F. Hypopituitarism. Pituitary. 2006;9:335–342.
- Van den Berghe G, de Zegher F, Bouillon R. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab. 1998;83:1827–1834.
- Desborough JP. The stress response to trauma and surgery. Br J Anaesthesia. 2000;85:109–117.
- Alavi SA, Tan CL, Menon DK, et al. Incidence of pituitary dysfunction following traumatic brain injury: A prospective study from a regional neurosurgical centre. Br J Neurosurg. 2016;30:302–306.